+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenotypic Characterization of a Family With An In-frame Deletion in the DMD Gene and Variable Penetrance



Phenotypic Characterization of a Family With An In-frame Deletion in the DMD Gene and Variable Penetrance



Current Gene Therapy 18(4): 246-251



Duchenne muscular dystrophy is a disorder with variable expression caused by framedisrupting mutations in the dystrophin gene. It is characterized by progressive muscle weakness and dilated cardiomyopathy. In-frame dystrophin mutations cause a clinically moderate disorder named Becker muscular dystrophy. Our aim was to study the clinical and genetic characteristics of a family with inherited cardiomyopathy and Becker muscular dystrophy. The index case was diagnosed with psychomotor retardation at 5 years of age. Asymmetric left ventricular hypertrophy and a long QT interval were evidenced at the age of 12. Mild muscular weakness was developed subsequently. Three genetic variants were identified in the index case: p.Arg891Alafs*160 in the MYBPC3 gene, p.Thr263Met in the KCNJ5 gene, and p.Ser2437_Ile2554delinsPhe in the DMD gene. The latter was expected to generate an in-frame deletion of exons 51 and 52 of the dystrophin gene. A family study revealed that the father and 3 uncles were carriers of the MYBPC3 mutation. The mother and a maternal grandfather were carriers of the other 2 variants. The 80-year-old grandfather, who had the dystrophin mutation, showed no sign of cardiomyopathy or muscular weakness. The deletion of exons 51 and 52 in the DMD gene, which has been proposed as one of the therapeutic strategies for Duchenne, is consistent with a normal life expectancy and the absence of myopathic symptoms in hemizygous males.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 065404146

Download citation: RISBibTeXText

PMID: 29984652


Related references

Phenotypic characterization of a family with long QT syndrome 13: a different type of variable penetrance. Heart Rhythm 10(10): 1507-1508, 2014

Variable penetrance of hypogonadism in a sibship with Kallmann syndrome due to a deletion of the KAL gene. American Journal of Medical Genetics 57(3): 476-478, 1995

Phenotypic characterization of Bbs4 null mice reveals age-dependent penetrance and variable expressivity. Human Genetics 120(2): 211-226, 2006

Variable phenotypic penetrance of thrombosis in adult mice after tissue-selective and temporally controlled Thbd gene inactivation. Blood Advances 1(15): 1148-1158, 2017

Van Der Woude syndrome: variable penetrance of a novel mutation (p.Arg 84Gly) of the IRF6 gene in a Turkish family. International Journal of Molecular Medicine 15(2): 247-251, 2005

Variable phenotypic penetrance of von Willebrand factor gene Y1584C heterozygosity in Type 1 von Willebrand disease families and its association with enhanced in vitro susceptibility to ADAMTS 13 mediated proteolysis. Blood 102(11): 311a, November 16, 2003

NRXN1 deletion syndrome; phenotypic and penetrance data from 34 families. European Journal of Medical Genetics 2018, 2018

In-frame deletion in the proteolipid protein gene of a family with Pelizaeus-Merzbacher disease. American Journal of Medical Genetics 55(4): 405-407, 1995

Novel exon 3B proteolipid protein gene mutation causing late-onset spastic paraplegia type 2 with variable penetrance in female family members. Annals of Neurology 45(5): 680-683, 1999

Molecular-genetic mapping of zebrafish mutants with variable phenotypic penetrance. Plos One 6(10): E26510, 2012

Novel in-frame deletion mutation in FLCN gene in a Korean family with recurrent primary spontaneous pneumothorax. Gene 499(2): 339-342, 2012

Phenotypic changes associated with deletion and overexpression of a stage-regulated gene family in Leishmania. Cellular Microbiology 3(8): 511-523, 2001

Deletion of the SH gene from avian metapneumovirus has a greater impact on virus production and immunogenicity in turkeys than deletion of the G gene or M2-2 open reading frame. Journal of General Virology 89(Pt 2): 525-533, 2008

Diagnostic screening identifies a wide range of mutations involving the SHOX gene, including a common 47.5 kb deletion 160 kb downstream with a variable phenotypic effect. American Journal of Medical Genetics. Part a 161a(6): 1329-1338, 2016

Characterization of the archaeal flagella operon via systematic In-frame gene deletion and complementation in Methanococcus maripaludis. 2007